# RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease

> **NCT00002462** · PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **European Organisation for Research and Treatment of Cancer - EORTC** · enrollment: 615 (actual)

## Conditions studied

- Lymphoma

## Interventions

- **BIOLOGICAL:** bleomycin sulfate
- **DRUG:** doxorubicin hydrochloride
- **DRUG:** mechlorethamine hydrochloride
- **DRUG:** prednisone
- **DRUG:** procarbazine hydrochloride
- **DRUG:** vinblastine sulfate
- **DRUG:** vincristine sulfate
- **RADIATION:** low-LET cobalt-60 gamma ray therapy
- **RADIATION:** low-LET photon therapy
- **RADIATION:** radiation therapy

## Key facts

- **NCT ID:** NCT00002462
- **Lead sponsor:** European Organisation for Research and Treatment of Cancer - EORTC
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 1989-09
- **Primary completion:** 2000-05
- **Final completion:** —
- **Target enrollment:** 615 (ACTUAL)
- **Last updated:** 2025-08-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002462

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002462, "RT or No RT Following Chemotherapy in Treating Patients With Stage III/IV Hodgkin's Disease". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00002462. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*